{"DataElement":{"publicId":"7122802","version":"1","preferredName":"QC Slide Review Normal Tissue Segment Identifier Integer","preferredDefinition":"A number used to identify the normal tissue segment collected as part of the quality control review of the tumor biospecimen for proteomic and genomic analysis.","longName":"7119485v1.0:6847952v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7119485","version":"1","preferredName":"QC Slide Review Normal Tissue Segment Identifier","preferredDefinition":"Tissue Source Sites (TSS) will perform a QC review of tumor biospecimens by review of slides from corresponding FFPE QC blocks. For each tumor segment, an H&E-stained slide is to be prepared and reviewed by the TSS pathologist to confirm accuracy of tissue diagnosis and tumor composition._Sufficient total material from each patient, divided to yield a minimum of one aliquot, preferably divided into one to three aliquots of non-neoplastic (\"normal\") adjacent tissue (as feasible) suitable for processing for proteomic and genomic analysis._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"7119479v1.0:7119483v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7119479","version":"1","preferredName":"QC Slide Review","preferredDefinition":"Tissue Source Sites (TSS) will perform a QC review of tumor biospecimens by review of slides from corresponding FFPE QC blocks. For each tumor segment, an H&E-stained slide is to be prepared and reviewed by the TSS pathologist to confirm accuracy of tissue diagnosis and tumor composition.","longName":"C162621","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"QC Slide Review","conceptCode":"C162621","definition":"Tissue Source Sites (TSS) will perform a QC review of tumor biospecimens by review of slides from corresponding FFPE QC blocks. For each tumor segment, an H&E-stained slide is to be prepared and reviewed by the TSS pathologist to confirm accuracy of tissue diagnosis and tumor composition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9B7BBAF3-5C07-56E9-E053-F662850AEDA0","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"ONEDATA","dateModified":"2020-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7119483","version":"1","preferredName":"Normal Tissue Segment Identifier","preferredDefinition":"Sufficient total material from each patient, divided to yield a minimum of one aliquot, preferably divided into one to three aliquots of non-neoplastic (\"normal\") adjacent tissue (as feasible) suitable for processing for proteomic and genomic analysis.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"C162623:C25364","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal Tissue Sample","conceptCode":"C162623","definition":"Tissue sample with cellular composition and architectural patterns expected for the particular anatomic site in which it belongs. There is no evidence of abnormal cellular infiltrates or tumor mass formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identifier","conceptCode":"C25364","definition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9B7C7170-8202-0570-E053-F662850AC409","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"ONEDATA","dateModified":"2020-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9B7C7170-8213-0570-E053-F662850AC409","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"KNABLEJ","dateModified":"2020-02-13","changeDescription":"1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set. 1/6/20 jk created for CPTAC Path Review and Local Path CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6847952","version":"1","preferredName":"Integer","preferredDefinition":"A positive number with no fractional part between 0 and 100.","longName":"6847952v1.0","context":"OCCPR","contextVersion":"1","type":"Non-enumerated","dataType":"Integer","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433737","version":"1","preferredName":"Integer","preferredDefinition":"A number with no fractional part.","longName":"C45255","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4769-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-25","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-25","modifiedBy":"ONEDATA","dateModified":"2005-11-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F867DFE-8763-5C6C-E053-F662850A9F8B","latestVersionIndicator":"Yes","beginDate":"2019-08-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-08-07","modifiedBy":"KNABLEJ","dateModified":"2020-01-22","changeDescription":"1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set.  8/7/19 jk created for CPTAC baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"7218867","version":"1","longName":"Head and Neck","context":"OCCPR"},{"publicId":"7634287","version":"1","longName":"HNSCC Pathology Review","context":"OCCPR"},{"publicId":"6601282","version":"1","longName":"Esophagus","context":"OCCPR"},{"publicId":"6779555","version":"1","longName":"ESCA Pathology Review","context":"OCCPR"},{"publicId":"6776734","version":"1","longName":"All Generic CRFs","context":"OCCPR"},{"publicId":"7252486","version":"1","longName":"Slide Creation","context":"OCCPR"},{"publicId":"5635361","version":"1","longName":"Bladder","context":"OCCPR"},{"publicId":"6779608","version":"1","longName":"BLCA Pathology Review","context":"OCCPR"},{"publicId":"6570064","version":"1","longName":"Stomach","context":"OCCPR"},{"publicId":"6779568","version":"1","longName":"STAD Pathology Review","context":"OCCPR"},{"publicId":"10000439","version":"1","longName":"Thyroid","context":"OCCPR"},{"publicId":"6779573","version":"1","longName":"THCA Pathology Review","context":"OCCPR"},{"publicId":"6776735","version":"1","longName":"Eye","context":"OCCPR"},{"publicId":"6779576","version":"1","longName":"UVM Pathology Review","context":"OCCPR"},{"publicId":"6570063","version":"1","longName":"Cervix","context":"OCCPR"},{"publicId":"6779611","version":"1","longName":"CESC Pathology Review","context":"OCCPR"},{"publicId":"6776762","version":"1","longName":"Bile duct and Liver","context":"OCCPR"},{"publicId":"6779540","version":"1","longName":"CHOL Pathology Review","context":"OCCPR"},{"publicId":"6779543","version":"1","longName":"LIHC Pathology Review","context":"OCCPR"},{"publicId":"5635376","version":"1","longName":"Prostate","context":"OCCPR"},{"publicId":"6779563","version":"1","longName":"PRAD Pathology Review","context":"OCCPR"},{"publicId":"6601275","version":"1","longName":"Brain","context":"OCCPR"},{"publicId":"6779546","version":"1","longName":"LGG Pathology Review","context":"OCCPR"},{"publicId":"10000348","version":"1","longName":"Melanoma","context":"OCCPR"},{"publicId":"7639000","version":"1","longName":"CM Pathology Review","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Normal Segment #","type":"Preferred Question Text","description":"Normal Segment #","url":null,"context":"OCCPR"},{"name":"CPTAC-Slide-1","type":"Alternate Question Text","description":"Normal Aliquot Number","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9B90F217-91B9-1C06-E053-F662850AE5EB","latestVersionIndicator":"Yes","beginDate":"2020-01-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-07","modifiedBy":"KNABLEJ","dateModified":"2021-08-17","changeDescription":"8/17/21 jk added CM Path Rpt CSI. 7/12/21 jk added HNSCC Path Rpt CSI. 6/14/20 jk added CPTAC ESCA Pathology CSI.  4/30/20 jk added CPTAC LGG Path CSI.  4/17/20 jk def mod per SME review to support Slide Creation CRF; alt quest added for \"Aliquot\". 1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set. 1/7/20 jk created for CPTAC Path Review and CRF; applicable to all tumor types.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}